US Stock MarketDetailed Quotes

PIRS Pieris Pharmaceuticals

Watchlist
  • 17.0000
  • +0.4300+2.60%
Close Dec 10 16:00 ET
  • 17.0000
  • 0.00000.00%
Post 20:01 ET
22.44MMarket Cap-1403P/E (TTM)

Pieris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
101.50%146K
88.98%-1.48M
36.38%-7M
10.20%-53.82M
-52.08%-19.67M
-10.77%-9.72M
13.78%-13.43M
51.44%-11M
-682.40%-59.93M
-18.17%-12.93M
Net income from continuing operations
73.15%-2.89M
-190.29%-3.59M
62.89%-4.89M
26.25%-24.54M
43.42%-4.58M
-10.44%-10.75M
138.46%3.98M
-158.44%-13.18M
27.24%-33.28M
15.00%-8.1M
Operating gains losses
---6K
----
----
85.90%-53K
--0
--0
---106K
--53K
---376K
---77K
Depreciation and amortization
--0
--0
-105.25%-30K
-35.94%1.78M
-138.12%-223K
-8.29%708K
24.36%725K
-32.02%571K
17.40%2.78M
-0.51%585K
Other non cash items
4,568.42%849K
-56.04%-284K
1,868.06%1.42M
-36.26%-124K
101.63%5K
-1,050.00%-19K
-247.97%-182K
-20.88%72K
-203.33%-91K
-448.21%-307K
Change In working capital
111.99%1.86M
111.60%2.19M
-752.88%-3.96M
-44.26%-48.14M
-139.71%-14.34M
-3,341.02%-15.52M
-159.26%-18.89M
103.09%607K
-209.32%-33.37M
-83.24%-5.98M
-Change in receivables
----
----
----
302.25%5.31M
----
----
----
----
-44.73%-2.62M
----
-Change in prepaid assets
----
----
----
174.96%1.02M
----
----
----
----
56.94%-1.36M
----
-Change in payables and accrued expense
----
----
----
61.95%-3.13M
----
----
----
----
-148.53%-8.21M
----
-Change in other current liabilities
----
----
----
-1,048.89%-11.37M
----
----
----
----
-0.20%-990K
----
-Change in other working capital
----
----
----
-98.00%-39.97M
----
----
----
----
-203.22%-20.19M
----
Cash from discontinued investing activities
Operating cash flow
101.50%146K
88.98%-1.48M
36.38%-7M
10.20%-53.82M
-52.08%-19.67M
-10.77%-9.72M
13.78%-13.43M
51.44%-11M
-682.40%-59.93M
-18.17%-12.93M
Investing cash flow
Cash flow from continuing investing activities
107.16%142K
259.30%2.18M
-24.39%9M
156.52%12M
211.56%3.45M
-136.27%-1.98M
87.43%-1.37M
170.23%11.9M
-2,137.72%-21.24M
423.68%1.11M
Net PPE purchase and sale
3,459.42%2.32M
--0
--0
83.57%-171K
18.18%13K
-102.94%-69K
89.35%-67K
87.66%-48K
-9.69%-1.04M
103.22%11K
Net investment purchase and sale
-13.63%-2.18M
267.51%2.18M
-24.69%9M
160.28%12.17M
213.50%3.44M
-134.79%-1.92M
87.31%-1.3M
172.17%11.95M
---20.2M
--1.1M
Cash from discontinued investing activities
Investing cash flow
107.16%142K
259.30%2.18M
-24.39%9M
156.52%12M
211.56%3.45M
-136.27%-1.98M
87.43%-1.37M
170.23%11.9M
-2,137.72%-21.24M
423.68%1.11M
Financing cash flow
Cash flow from continuing financing activities
0
174.40%19.8M
-84.95%14K
0
-87.80%7.21M
-98.10%93K
Net common stock issuance
--0
----
----
185.02%19.73M
--0
--0
----
----
-87.88%6.92M
--0
Proceeds from stock option exercised by employees
--0
----
----
-77.40%66K
-84.95%14K
--0
----
----
-85.59%292K
-60.43%93K
Cash from discontinued financing activities
Financing cash flow
--0
----
----
174.40%19.8M
-84.95%14K
--0
----
----
-87.80%7.21M
-98.10%93K
Net cash flow
Beginning cash position
-56.09%19.73M
-51.98%19.08M
-54.97%17.4M
-67.19%38.64M
-32.07%32.89M
-17.18%44.94M
-52.54%39.74M
-67.19%38.64M
67.19%117.76M
-61.28%48.42M
Current changes in cash
102.46%288K
-86.04%696K
120.95%2M
70.22%-22.02M
-38.12%-16.21M
-286.88%-11.71M
119.05%4.98M
102.75%907K
-246.39%-73.95M
-83.76%-11.73M
Effect of exchange rate changes
-94.66%-656K
-123.11%-49K
-258.00%-316K
115.13%783K
-63.60%708K
88.00%-337K
106.39%212K
120.12%200K
-62.23%-5.18M
315.39%1.95M
End cash Position
-41.14%19.36M
-56.09%19.73M
-51.98%19.08M
-54.97%17.4M
-54.97%17.4M
-32.07%32.89M
-17.18%44.94M
-52.54%39.74M
-67.19%38.64M
-67.19%38.64M
Free cash flow
101.49%146K
89.04%-1.48M
36.65%-7M
11.45%-53.99M
-52.11%-19.66M
-11.12%-9.79M
16.71%-13.5M
52.05%-11.04M
-608.25%-60.97M
-14.50%-12.92M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 101.50%146K88.98%-1.48M36.38%-7M10.20%-53.82M-52.08%-19.67M-10.77%-9.72M13.78%-13.43M51.44%-11M-682.40%-59.93M-18.17%-12.93M
Net income from continuing operations 73.15%-2.89M-190.29%-3.59M62.89%-4.89M26.25%-24.54M43.42%-4.58M-10.44%-10.75M138.46%3.98M-158.44%-13.18M27.24%-33.28M15.00%-8.1M
Operating gains losses ---6K--------85.90%-53K--0--0---106K--53K---376K---77K
Depreciation and amortization --0--0-105.25%-30K-35.94%1.78M-138.12%-223K-8.29%708K24.36%725K-32.02%571K17.40%2.78M-0.51%585K
Other non cash items 4,568.42%849K-56.04%-284K1,868.06%1.42M-36.26%-124K101.63%5K-1,050.00%-19K-247.97%-182K-20.88%72K-203.33%-91K-448.21%-307K
Change In working capital 111.99%1.86M111.60%2.19M-752.88%-3.96M-44.26%-48.14M-139.71%-14.34M-3,341.02%-15.52M-159.26%-18.89M103.09%607K-209.32%-33.37M-83.24%-5.98M
-Change in receivables ------------302.25%5.31M-----------------44.73%-2.62M----
-Change in prepaid assets ------------174.96%1.02M----------------56.94%-1.36M----
-Change in payables and accrued expense ------------61.95%-3.13M-----------------148.53%-8.21M----
-Change in other current liabilities -------------1,048.89%-11.37M-----------------0.20%-990K----
-Change in other working capital -------------98.00%-39.97M-----------------203.22%-20.19M----
Cash from discontinued investing activities
Operating cash flow 101.50%146K88.98%-1.48M36.38%-7M10.20%-53.82M-52.08%-19.67M-10.77%-9.72M13.78%-13.43M51.44%-11M-682.40%-59.93M-18.17%-12.93M
Investing cash flow
Cash flow from continuing investing activities 107.16%142K259.30%2.18M-24.39%9M156.52%12M211.56%3.45M-136.27%-1.98M87.43%-1.37M170.23%11.9M-2,137.72%-21.24M423.68%1.11M
Net PPE purchase and sale 3,459.42%2.32M--0--083.57%-171K18.18%13K-102.94%-69K89.35%-67K87.66%-48K-9.69%-1.04M103.22%11K
Net investment purchase and sale -13.63%-2.18M267.51%2.18M-24.69%9M160.28%12.17M213.50%3.44M-134.79%-1.92M87.31%-1.3M172.17%11.95M---20.2M--1.1M
Cash from discontinued investing activities
Investing cash flow 107.16%142K259.30%2.18M-24.39%9M156.52%12M211.56%3.45M-136.27%-1.98M87.43%-1.37M170.23%11.9M-2,137.72%-21.24M423.68%1.11M
Financing cash flow
Cash flow from continuing financing activities 0174.40%19.8M-84.95%14K0-87.80%7.21M-98.10%93K
Net common stock issuance --0--------185.02%19.73M--0--0---------87.88%6.92M--0
Proceeds from stock option exercised by employees --0---------77.40%66K-84.95%14K--0---------85.59%292K-60.43%93K
Cash from discontinued financing activities
Financing cash flow --0--------174.40%19.8M-84.95%14K--0---------87.80%7.21M-98.10%93K
Net cash flow
Beginning cash position -56.09%19.73M-51.98%19.08M-54.97%17.4M-67.19%38.64M-32.07%32.89M-17.18%44.94M-52.54%39.74M-67.19%38.64M67.19%117.76M-61.28%48.42M
Current changes in cash 102.46%288K-86.04%696K120.95%2M70.22%-22.02M-38.12%-16.21M-286.88%-11.71M119.05%4.98M102.75%907K-246.39%-73.95M-83.76%-11.73M
Effect of exchange rate changes -94.66%-656K-123.11%-49K-258.00%-316K115.13%783K-63.60%708K88.00%-337K106.39%212K120.12%200K-62.23%-5.18M315.39%1.95M
End cash Position -41.14%19.36M-56.09%19.73M-51.98%19.08M-54.97%17.4M-54.97%17.4M-32.07%32.89M-17.18%44.94M-52.54%39.74M-67.19%38.64M-67.19%38.64M
Free cash flow 101.49%146K89.04%-1.48M36.65%-7M11.45%-53.99M-52.11%-19.66M-11.12%-9.79M16.71%-13.5M52.05%-11.04M-608.25%-60.97M-14.50%-12.92M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data